/
Eur J Neurol
The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort
- E. Carnero Contentti
- C. Pestchanker
- E. Ciampi
- S. Castro Suarez
- C. Caparo Zamalloa
- V. Daccach Marques
- K. Messias
- J.I. Gortari
- V. Tkachuk
- B. Silva
- C. Mainella
- S. Reyes
- J. Toro
- J. Rodriguez
- E. Correa-Diaz
- J.I. Rojas
- F. Paul